Compare RLMD & CRNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLMD | CRNC |
|---|---|---|
| Founded | 2004 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 319.7M | 316.0M |
| IPO Year | 2012 | 2019 |
| Metric | RLMD | CRNC |
|---|---|---|
| Price | $7.10 | $6.77 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $12.40 | $10.00 |
| AVG Volume (30 Days) | ★ 1.8M | 574.3K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 45.28 | ★ 96.95 |
| EPS | N/A | ★ N/A |
| Revenue | $13,070.00 | ★ $251,781,000.00 |
| Revenue This Year | N/A | $27.17 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 154.83 | N/A |
| 52 Week Low | $0.24 | $5.85 |
| 52 Week High | $7.41 | $13.74 |
| Indicator | RLMD | CRNC |
|---|---|---|
| Relative Strength Index (RSI) | 66.73 | 42.43 |
| Support Level | $3.49 | $6.41 |
| Resistance Level | $7.41 | $7.42 |
| Average True Range (ATR) | 0.46 | 0.35 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 84.62 | 57.57 |
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.